Clinical trials

• Health & Medicine
• Science & Technology

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer. We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

6 June 2017

• Health & Medicine

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

6 June 2017

• Health & Medicine

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available. Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

6 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• Health & Medicine

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread. Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.

3 June 2017

• Health & Medicine

Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent. Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.

3 June 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 4

We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves. We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves.

23 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 3

We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves. We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves.

22 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 2

We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves. We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves.

21 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 1

We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves. We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves.

20 May 2017

• Health & Medicine

Vaccine may reduce HPV infections that cause some oral cancers

Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated. Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated.

19 May 2017

• Health & Medicine

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer. Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

5 May 2017